Quince Therapeutics (QNCX) EPS (Basic) (2018 - 2026)
Quince Therapeutics (QNCX) posted quarterly EPS (Basic) of $71.91 for Q1 2026, up 205.12% year-over-year from $23.57 in Q1 2025, and up 193.42% quarter-over-quarter from -$76.98 in Q4 2025.
Quince Therapeutics (QNCX) EPS (Basic) (2018 - 2026) Analysis & Trends
Quince Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at $71.91 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 205.12% year-over-year to $71.91; the TTM figure through Mar 2026 stood at -$35.04 (up 87.32% YoY), while the FY2025 annual figure was -$254.72, up 3.04% from the prior year.
- EPS (Basic) for Q1 2026 stood at $71.91, up from -$76.98 in the prior quarter.
- The five-year high for EPS (Basic) was $71.91 in Q1 2026, with the low at -$143.63 in Q1 2022.
- The 5-year median for EPS (Basic) is -$51.84 (2024), against an average of -$55.99.
- The sharpest annual moves came in 2024 and 2026: EPS (Basic) tumbled 372.98% in 2024, then surged 205.12% in 2026.
- Quince Therapeutics' EPS (Basic) stood at -$33.04 in 2022, then slumped by 44.57% to -$47.77 in 2023, then slipped by 20.56% to -$57.59 in 2024, then tumbled by 33.67% to -$76.98 in 2025, then jumped by 193.42% to $71.91 in 2026.
- Business Quant data shows QNCX's EPS (Basic) at $71.91 in Q1 2026, -$76.98 in Q4 2025, and -$49.83 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - | -12.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.91 |
| Dec 31, 2025 | -76.98 |
| Sep 30, 2025 | -49.83 |
| Jun 30, 2025 | -68.75 |
| Mar 31, 2025 | -68.41 |
| Dec 31, 2024 | -57.59 |
| Sep 30, 2024 | -25.45 |
| Jun 30, 2024 | -128.68 |
| Mar 31, 2024 | -51.84 |
| Dec 31, 2023 | -47.77 |
| Sep 30, 2023 | -29.67 |
| Jun 30, 2023 | -27.21 |
| Mar 31, 2023 | -68.35 |
| Dec 31, 2022 | -33.04 |
| Sep 30, 2022 | -44.48 |
| Jun 30, 2022 | -102.04 |
| Mar 31, 2022 | -143.63 |
| Dec 31, 2021 | 447.84 |
| Sep 30, 2021 | -145.84 |
| Jun 30, 2021 | -147.05 |